Advancing the Discussion and Management of Vasomotor Symptoms Associated With Menopause

CME: 0.5

Target Audience

This activity has been designed to meet the educational needs of obstetrician/gynecologists (OB/GYNs), OB/GYN nurse practitioners (NPs), physician assistants (PAs) and registered nurses (RNs), as well as primary care clinicians (physicians, NPs, PAs, and RNs) who manage patients with menopause-associated vasomotor symptoms (VMS).

Program Overview

Are you up to date on the latest therapeutic targets for managing menopause-associated VMS? This activity will enable you to gain insights from the experts as they:

  • Identify factors contributing to VMS
  • Discuss approaches to addressing the undertreatment of VMS
  • Review currently available treatments for VMS, including hormonal and nonhormonal therapies
  • Explore novel targets and nonhormonal investigational agents for treating VMS
  • Recognize patient types that might be appropriate candidates for novel agents for VMS

Learning Objectives

After participating in the activity, learners should be better able to:

  • DELINEATE factors contributing to the undertreatment of VMS associated with menopause and its impact on patient quality of life and well-being
  • EVALUATE evidence-based, patient-specific management plans for VMS based on the efficacy, safety, and appropriateness of available therapeutic options for specific patients
  • DESCRIBE neuronal pathways targeted by investigative therapeutics and the clinical trial data related to these therapeutics
  • IDENTIFY patient types who may be appropriate for therapies under investigation for the treatment of VMS associated with menopause

Post a comment to this article